These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6605114)

  • 1. [Effect of human lymphoblast interferon in adult T-cell leukemia and non-Hodgkin's lymphoma].
    Kamihira S; Soda H; Kinoshita K; Ichimaru M
    Gan To Kagaku Ryoho; 1983 Oct; 10(10):2188-93. PubMed ID: 6605114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical trial of human lymphoblastoid interferon on advanced malignancy].
    Usui N; Ogawa M; Inagaki J; Horikoshi N; Inoue K; Miyamoto H; Ikeda K; Nakada H; Adachi K; Okada Y
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2324-9. PubMed ID: 6357102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
    Ozer H; Gavigan M; O'Malley J; Thompson D; Dadey B; Nussbaum-Blumenson A; Snider C; Rudnick S; Ferraresi R; Norred S
    J Biol Response Mod; 1983; 2(6):499-515. PubMed ID: 6607323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of leukemias and lymphomas with interferons: III. Trial treatment of meningeal localizations of acute leukemia and non-Hodgkin's lymphomas with beta interferon administered by the intrathecal route].
    Misset JL; Mathé G; Gastiaburu J; Goutner A; Dorval TI; Gouveia J; Hayat M; Jasmin C; Schwarzenberg L; Machover D; Ribaud P; de Vassal F; Horoszewicz JP
    Biomed Pharmacother; 1982; 36(3):167-70. PubMed ID: 6758874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical study on the effect of natural alpha-interferon (HLBI) in the treatment of adult T-cell leukemia].
    Ichimaru M; Kamihira S; Moriuchi Y; Kuraishi Y; Usui N; Toki H; Okabe K; Niho Y; Shibuya T; Umei T
    Gan To Kagaku Ryoho; 1988 Oct; 15(10):2975-81. PubMed ID: 3052302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.
    Proctor SJ; Taylor PR; Angus B; Wood K; Lennard AL; Lucraft H; Carey PJ; Stark A; Iqbal A; Haynes A; Russel N; Leonard RC; Culligan D; Conn J; Jackson GH
    Eur J Haematol Suppl; 2001 Jul; 64():28-32. PubMed ID: 11486397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of topical injections of native alpha-interferon (HLBI) in the treatment of skin lesions of adult T cell leukemia: report of a case].
    Sugie Y; Hayashi S; Shibuya T; Otsuka T; Okamura T; Harada M; Niho Y
    Rinsho Ketsueki; 1990 Apr; 31(4):497-501. PubMed ID: 2381068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-dependent cytotoxic action of human recombinant alpha-interferon (Ro22-8181) in vitro and the sensitivity of various cultured leukemia and lymphoma cell lines to it.
    Shibata T; Shimada Y; Shimoyama M
    Jpn J Clin Oncol; 1985 Mar; 15(1):67-75. PubMed ID: 3981816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A cooperative phase I-II study of HLBI in patients with malignant tumors].
    Kimura K
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1324-31. PubMed ID: 6329104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-interferon as maintenance drug after initial fludarabine therapy for patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphoma.
    Zinzani PL; Levrero MG; Lauria F; Rondelli D; Zaja F; Russo D; Fanin R; De Rossi G; Mauro FR; Bendandi M; Gozzetti A; Dianzani F; Mandelli F; Tura S
    Haematologica; 1994; 79(1):55-60. PubMed ID: 15378949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical study on the effect of human lymphoblastoid interferon in multiple myeloma].
    Takeyama H; Yano K; Kataoka T; Yamamoto M; Emi N; Kodera Y; Kawashima K; Ohno R; Yokomaku S; Kobayashi M
    Gan To Kagaku Ryoho; 1983 Sep; 10(9):2043-8. PubMed ID: 6614939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Introduction of natural interferon-alpha "Sumiferon"].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2800-3. PubMed ID: 3631977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group.
    Santini G; Coser P; Congiu AM; Salvagno L; De Souza C; Sertoli MR; Olivieri A; Chisesi T; Rubagotti A; Truini M; Contu A; Porcellini A; Zambaldi G; Nati S; Marino G; Rizzoli V
    Haematologica; 2000 Feb; 85(2):160-6. PubMed ID: 10681723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical effects of human lymphoblastoid interferon in patients with hematologic neoplasms].
    Oda Y; Irie S; Inagaki M; Fukumoto M; Ueda I; Ohmoto E; Fujimoto S; Endo Y; Watanabe S; Lai M; Takahashi I; Kimura I; Ishii H; Sezaki T
    Gan To Kagaku Ryoho; 1983 May; 10(5):1313-9. PubMed ID: 6575725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phase II study of recombinant leukocyte A interferon (Ro 22-8181) in hematological malignancies].
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):928-35. PubMed ID: 3885864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of non-Hodgkin's lymphoma with NK-631 (peplomycin)--with special reference to the effect on T and non-T cell lymphomas].
    Kamihira S; Jinnai I; Kinoshita K; Ichimaru M
    Gan To Kagaku Ryoho; 1982 Feb; 9(2):289-92. PubMed ID: 6191697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
    Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical outcomes of patients with peripheral T-cell lymphoma (PTCL) treated by EPOCH regimen].
    Peng YL; Huang HQ; Lin XB; Xia ZJ; Li YH; Wang W; He YJ; Pan ZH; Jiang WQ; Guan ZZ
    Ai Zheng; 2004 Aug; 23(8):943-6. PubMed ID: 15301720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engraftment of HLA-matched sibling hematopoietic stem cells after immunosuppressive conditioning regimen in patients with hematologic neoplasias.
    Carella AM; Lerma E; Dejana A; Corsetti MT; Celesti L; Bruni R; Benvenuto F; Figari O; Parodi C; Carlier P; Florio G; Lercari G; Valbonesi M; Casarino L; De Stefano F; Geniram A; Venturino M; Tedeschi L; Palmieri G; Piaggio G; Podestà M; Frassoni F; Van Lint MT; Marmont AM; Bacigalupo A
    Haematologica; 1998 Oct; 83(10):904-9. PubMed ID: 9830799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.